Geneos Wealth Management’s ICL Group ICL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$996 Hold
200
﹤0.01% 2425
2026
Q1
$1.03K Hold
200
﹤0.01% 2399
2025
Q4
$1.14K Hold
200
﹤0.01% 2395
2025
Q3
$1.25K Sell
200
-501
-71% -$3.22K ﹤0.01% 2383
2025
Q2
$4.82K Buy
701
+501
+251% +$3.27K ﹤0.01% 2591
2025
Q1
$1.12K Buy
+200
New +$1.18K ﹤0.01% 2910
2024
Q4
Sell
-200
Closed -$854 2924
2024
Q3
$854 Hold
200
﹤0.01% 2473
2024
Q2
$868 Hold
200
﹤0.01% 2000
2024
Q1
$1.06K Hold
200
﹤0.01% 2005
2023
Q4
$1.01K Hold
200
﹤0.01% 2012
2023
Q3
$1.1K Hold
200
﹤0.01% 2018
2023
Q2
$1.09K Hold
200
﹤0.01% 2011
2023
Q1
$1.34K Hold
200
﹤0.01% 1960
2022
Q4
$1.45K Hold
200
﹤0.01% 1922
2022
Q3
$1K Hold
200
﹤0.01% 1934
2022
Q2
$1K Buy
200
+16
+9% +$177 ﹤0.01% 2499
2022
Q1
$2K Buy
+184
New +$1.95K ﹤0.01% 2546

Other funds holding ICL

Geneos Wealth Management's ICL Position: Q2 2026 in Review

Geneos Wealth Management held its ICL Group (ICL) position steady in Q2 2026 at 200 shares worth $996. The position accounts for ﹤0.01% of the portfolio, ranked #2425.

Geneos Wealth Management first reported a position in ICL in Q1 2022 and has held it in 17 quarters since. The position peaked at $4.82K in Q2 2025. 220 funds tracked by Wall St. Rank hold ICL as of Q2 2026.

  • Geneos Wealth Management held 200 shares of ICL Group worth $996 as of Q2 2026.
  • Geneos Wealth Management left its ICL Group share count unchanged in Q2 2026.
  • ICL Group made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2425 holding.
  • Geneos Wealth Management first reported a position in ICL Group in Q1 2022 and has held it in 17 quarters since.
  • Geneos Wealth Management's ICL Group position peaked at $4.82K in Q2 2025.
  • 220 funds tracked by Wall St. Rank held ICL Group as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.